Segal Lloyd Mitchell's Form 4 filing
Repare Therapeutics Inc. (RPTX) · filed Mar 27, 2024
- Accession no.
- 0001415889-24-009249
- Filed
- Mar 27, 2024
- Trade date
- Mar 25-27, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $37.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Segal Lloyd MitchellCIK 0001477123 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | Common Shares | SSaleDisposed | −2,650 | $4.79 | −$12,693.5 | 89,166 | Indirect | |
| Mar 26, 2024 | Common Shares | SSaleDisposed | −2,650 | $4.64 | −$12,296 | 86,516 | Indirect | |
| Mar 27, 2024 | Common Shares | SSaleDisposed | −2,650 | $4.63 | −$12,269.5 | 83,866 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.